Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
49 studies found for:    Open Studies | "Bacteremia"
Show Display Options
Rank Status Study
1 Recruiting A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Condition: Bacteremia
Interventions: Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: Cefazolin
2 Recruiting Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment durations;   Other: 14 days of adequate antibiotic treatment durations
3 Not yet recruiting Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia
Condition: Bacteremia
Interventions: Drug: Continuous infusion of beta-lactam antibiotics .;   Other: Therapeutic drug monitoring of beta-lactam antibiotics.
4 Recruiting Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
Condition: Bacteremia
Intervention:
5 Recruiting Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
Condition: Bacteremia
Interventions: Drug: DSTA4637S;   Drug: Placebo;   Drug: SOC
6 Not yet recruiting Antibiotic Durations for Gram-negative Bacteremia
Condition: Bacteraemia Caused by Gram-Negative Bacteria
Interventions: Other: "Fixed long" antibiotic course of 14 days;   Other: "Fixed short" antibiotic course of 7 days;   Other: "Individualized duration" of antibiotic therapy
7 Recruiting Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia
Condition: Gram Negative Bacteremia
Interventions: Drug: short-course antibiotic treatment;   Drug: accepted prolonged antibiotic treatment
8 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin 10mg/kg/24h iv
9 Recruiting The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia
Intervention: Procedure: FDG PET CT
10 Not yet recruiting Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia
Interventions: Drug: Ceftobiprole medocaril;   Drug: Daptomycin
11 Recruiting BALANCE on the Wards: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment;   Other: 14 days of adequate antibiotic treatment
12 Recruiting Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Conditions: Methicillin Susceptible Staphylococcus Aureus Septicemia;   Bacteremia
Interventions: Drug: Daptomycin;   Other: Placebo
13 Recruiting An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures
Conditions: Bacteraemia;   Endocarditis
Interventions: Drug: Amoxicillin;   Drug: Amoxicillin-Potassium Clavulanate
14 Recruiting IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Condition: Bacteremia
Interventions: Drug: Daptomycin;   Drug: Vancomycin;   Drug: Ceftaroline
15 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
16 Not yet recruiting Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
Conditions: Staphylococcus Aureus Bacteremia;   Right-Sided Staphylococcus Aureus Endocarditis
Interventions: Biological: CF-301;   Drug: Placebo
17 Not yet recruiting Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
Condition: Infective Endocarditis, Bacteremia
Interventions: Drug: Dalbavancin;   Drug: Standard of Care
18 Recruiting Safety Evaluation of Seraph® to Reduce Bacteremia in Patients on Hemodialysis
Conditions: Bacteremia;   Bacterial Infection
Intervention: Device: Seraph Microbind Affinity Blood Filter
19 Recruiting Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.
Conditions: Bacteremia;   Infant, Very Low Birth Weight
Interventions: Device: Edelvaiss Multiline NEO;   Device: Standard Infusion Set
20 Recruiting T2Bacteria Panel Pivotal Study
Condition: Bacteremia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.